Because the origin of ulcers
is directly related to the reduction of the mucus barrier, we propose
that the gastroprotective action promoted by b-myrcene
could be related to its ability to increase the amount of gastric mucus.
Treatment with b-myrcene caused an increase in the amount
of adhered gastric mucus compared to the vehicle-treated group.